BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koutny F, Weghuber D, Bollow E, Greber-Platzer S, Hartmann K, Körner A, Reinehr T, Roebl M, Simic-Schleicher G, Wabitsch M, Widhalm K, Wiegand S, Holl RW. Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German-speaking countries. Analysis of the APV initiative. Pediatr Obes 2020;15:e12601. [PMID: 31810110 DOI: 10.1111/ijpo.12601] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Valle-Martos R, Jiménez-Reina L, Cañete R, Martos R, Valle M, Cañete MD. Changes in liver enzymes are associated with changes in insulin resistance, inflammatory biomarkers and leptin in prepubertal children with obesity. Ital J Pediatr 2023;49:29. [PMID: 36894963 DOI: 10.1186/s13052-023-01434-7] [Reference Citation Analysis]
2 Bergmann K, Stefanska A, Krintus M, Szternel L, Panteghini M, Sypniewska G. Association between Fasting and Postprandial Levels of Liver Enzymes with Metabolic Syndrome and Suspected Prediabetes in Prepubertal Children. Int J Mol Sci 2023;24. [PMID: 36674606 DOI: 10.3390/ijms24021090] [Reference Citation Analysis]
3 Prinz N, Putri RR, Reinehr T, Danielsson P, Weghuber D, Norman M, Rochow N, Marcus C, Holl RW, Hagman E. The association between perinatal factors and cardiometabolic risk factors in children and adolescents with overweight or obesity: A retrospective two-cohort study. PLoS Med 2023;20:e1004165. [PMID: 36638094 DOI: 10.1371/journal.pmed.1004165] [Reference Citation Analysis]
4 Schwarz C, Chromy D, Bauer D, Duong N, Schmidbauer VU, Schwarz M, Mandorfer M, Rieger A, Trauner M, Gschwantler M, Reiberger T. Prevalence and dynamics of NAFLD-associated fibrosis in people living with HIV in Vienna from first presentation to last follow-up. Wien Klin Wochenschr 2022. [PMID: 36576556 DOI: 10.1007/s00508-022-02133-9] [Reference Citation Analysis]
5 Kondakis K, Grammatikaki E, Kondakis M, Molnar D, Gómez-Martínez S, González-Gross M, Kafatos A, Manios Y, Pavón DJ, Gottrand F, Beghin L, Kersting M, Castillo MJ, Moreno LA, De Henauw S. Developing a risk assessment tool for identifying individuals at high risk for developing insulin resistance in European adolescents: the HELENA-IR score. J Pediatr Endocrinol Metab 2022;35:1518-27. [PMID: 36408818 DOI: 10.1515/jpem-2022-0265] [Reference Citation Analysis]
6 Chylińska-Frątczak A, Pietrzak I, Michalak A, Wyka K, Szadkowska A. Autoimmune reaction against pancreatic beta cells in children and adolescents with simple obesity. Front Endocrinol (Lausanne) 2022;13:1061671. [PMID: 36589801 DOI: 10.3389/fendo.2022.1061671] [Reference Citation Analysis]
7 Maruszczak K, Radzikowski K, Schütz S, Mangge H, Bergsten P, Forslund A, Manell H, Pixner T, Ahlström H, Kullberg J, Mörwald K, Weghuber D. Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease. Front Endocrinol 2022;13:1004128. [DOI: 10.3389/fendo.2022.1004128] [Reference Citation Analysis]
8 Li X, Ge J, He L. Influence of Self-Practice Oriented Teaching plus Psychological Intervention on Blood Glucose Level and Psychological State in Patients with Type 2 Diabetes Mellitus on Insulin Therapy. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-7. [DOI: 10.1155/2022/5606697] [Reference Citation Analysis]
9 Mastromauro C, Polidori N, Giannini C. Metabolic dysfunction-associated fatty liver disease in obese youth with insulin resistance and type 2 diabetes. Curr Opin Pediatr 2022;34:414-22. [PMID: 35836399 DOI: 10.1097/MOP.0000000000001138] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Julian V, Bergsten P, Forslund A, Ahlstrom H, Ciba I, Dahlbom M, Furthner D, Gomahr J, Kullberg J, Maruszczak K, Morwald K, Olsson R, Pixner T, Schneider A, Pereira B, Thivel D, Weghuber D. Sedentary time has a stronger impact on metabolic health than moderate to vigorous physical activity in adolescents with obesity: a cross-sectional analysis of the Beta-JUDO study. Pediatr Obes 2022;17:e12897. [PMID: 35083885 DOI: 10.1111/ijpo.12897] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Pedicelli S, Fintini D, Ravà L, Inzaghi E, Deodati A, Spreghini MR, Bizzarri C, Mariani M, Cianfarani S, Cappa M, Manco M. Prevalence of prediabetes in children and adolescents by class of obesity. Pediatr Obes 2022;17:e12900. [PMID: 35144324 DOI: 10.1111/ijpo.12900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Julian V, Ciba I, Olsson R, Dahlbom M, Furthner D, Gomahr J, Maruszczak K, Morwald K, Pixner T, Schneider A, Pereira B, Duclos M, Weghuber D, Thivel D, Bergsten P, Forslund A. Association between Metabolic Syndrome Diagnosis and the Physical Activity-Sedentary Profile of Adolescents with Obesity: A Complementary Analysis of the Beta-JUDO Study. Nutrients 2021;14:60. [PMID: 35010936 DOI: 10.3390/nu14010060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Putri RR, Casswall T, Hagman E. Risk and protective factors of non-alcoholic fatty liver disease in paediatric obesity: A nationwide nested case-control study. Clin Obes 2021;:e12502. [PMID: 34873855 DOI: 10.1111/cob.12502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Koutny F, Stein R, Kiess W, Weghuber D, Körner A. Elevated transaminases potentiate the risk for emerging dysglycemia in children with overweight and obesity. Pediatr Obes 2021;16:e12822. [PMID: 34155821 DOI: 10.1111/ijpo.12822] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
15 Vitebskaya AV, Popovich AV. Impairment of carbohydrate metabolism in children and adolescents with obesity. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2021-11-174-182] [Reference Citation Analysis]
16 Putri RR, Casswall T, Hagman E. Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity - a nationwide cross-sectional cohort study. BMC Pediatr 2021;21:271. [PMID: 34107897 DOI: 10.1186/s12887-021-02747-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Flisiak-Jackiewicz M, Bobrus-Chociej A, Wasilewska N, Lebensztejn DM. From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-New Terminology in Pediatric Patients as a Step in Good Scientific Direction? J Clin Med 2021;10:924. [PMID: 33804296 DOI: 10.3390/jcm10050924] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
18 Valle-Martos R, Valle M, Martos R, Cañete R, Jiménez-Reina L, Cañete MD. Liver Enzymes Correlate With Metabolic Syndrome, Inflammation, and Endothelial Dysfunction in Prepubertal Children With Obesity. Front Pediatr 2021;9:629346. [PMID: 33665176 DOI: 10.3389/fped.2021.629346] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
19 Leong KSW, Jayasinghe TN, Wilson BC, Derraik JGB, Albert BB, Chiavaroli V, Svirskis DM, Beck KL, Conlon CA, Jiang Y, Schierding W, Vatanen T, Holland DJ, O'Sullivan JM, Cutfield WS. High prevalence of undiagnosed comorbidities among adolescents with obesity. Sci Rep 2020;10:20101. [PMID: 33208826 DOI: 10.1038/s41598-020-76921-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Tanase DM, Gosav EM, Costea CF, Ciocoiu M, Lacatusu CM, Maranduca MA, Ouatu A, Floria M. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD).J Diabetes Res. 2020;2020:3920196. [PMID: 32832560 DOI: 10.1155/2020/3920196] [Cited by in Crossref: 55] [Cited by in F6Publishing: 65] [Article Influence: 18.3] [Reference Citation Analysis]
21 Koutny F, Weghuber D, Bollow E, Greber-Platzer S, Hartmann K, Körner A, Reinehr T, Roebl M, Simic-Schleicher G, Wabitsch M, Widhalm K, Wiegand S, Holl RW. Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German-speaking countries. Analysis of the APV initiative. Pediatr Obes 2020;15:e12601. [PMID: 31810110 DOI: 10.1111/ijpo.12601] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
22 Reinhardt D. Kinder mit hohem Diabetesrisiko erkennen. MMW Fortschr Med 2020;162:33. [PMID: 32189267 DOI: 10.1007/s15006-020-0256-7] [Reference Citation Analysis]